Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897225419> ?p ?o ?g. }
- W2897225419 endingPage "221" @default.
- W2897225419 startingPage "210" @default.
- W2897225419 abstract "Abstract Purpose: Transcriptomic profiling can shed light on the biology of small-cell bladder cancer (SCBC), nominating biomarkers, and novel therapeutic targets. Experimental Design: Sixty-three patients with SCBC had small-cell histology confirmed and quantified by a genitourinary pathologist. Gene expression profiling was performed for 39 primary tumor samples, 1 metastatic sample, and 6 adjacent normal urothelium samples (46 total) from the same cohort. Protein levels of differentially expressed therapeutic targets, DLL3 and PDL1, and also CD56 and ASCL1, were confirmed by IHC. A SCBC PDX model was utilized to assess in vivo efficacy of DLL3-targeting antibody–drug conjugate (ADC). Results: Unsupervised hierarchical clustering of 46 samples produced 4 clusters that correlated with clinical phenotypes. Patients whose tumors had the most “normal-like” pattern of gene expression had longer overall survival (OS) compared with the other 3 clusters while patients with the most “metastasis-like” pattern had the shortest OS (P = 0.047). Expression of DLL3, PDL1, ASCL1, and CD56 was confirmed by IHC in 68%, 30%, 52%, and 81% of tissue samples, respectively. In a multivariate analysis, DLL3 protein expression on >10% and CD56 expression on >30% of tumor cells were both prognostic of shorter OS (P = 0.03 each). A DLL3-targeting ADC showed durable antitumor efficacy in a SCBC PDX model. Conclusions: Gene expression patterns in SCBC are associated with distinct clinical phenotypes ranging from more indolent to aggressive disease. Overexpression of DLL3 mRNA and protein is common in SCBC and correlates with shorter OS. A DLL3-targeted ADC demonstrated in vivo efficacy superior to chemotherapy in a PDX model of SCBC." @default.
- W2897225419 created "2018-10-26" @default.
- W2897225419 creator A5002996984 @default.
- W2897225419 creator A5004894140 @default.
- W2897225419 creator A5005026596 @default.
- W2897225419 creator A5014882044 @default.
- W2897225419 creator A5017841270 @default.
- W2897225419 creator A5020173253 @default.
- W2897225419 creator A5024291093 @default.
- W2897225419 creator A5024482335 @default.
- W2897225419 creator A5025529463 @default.
- W2897225419 creator A5026717218 @default.
- W2897225419 creator A5031016267 @default.
- W2897225419 creator A5031234862 @default.
- W2897225419 creator A5034716746 @default.
- W2897225419 creator A5036587861 @default.
- W2897225419 creator A5049749003 @default.
- W2897225419 creator A5053008003 @default.
- W2897225419 creator A5056587248 @default.
- W2897225419 creator A5057043467 @default.
- W2897225419 creator A5069069312 @default.
- W2897225419 creator A5070471092 @default.
- W2897225419 creator A5077333954 @default.
- W2897225419 creator A5085120914 @default.
- W2897225419 creator A5085460226 @default.
- W2897225419 date "2019-01-01" @default.
- W2897225419 modified "2023-10-05" @default.
- W2897225419 title "Transcriptomic and Protein Analysis of Small-cell Bladder Cancer (SCBC) Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic Target" @default.
- W2897225419 cites W1553297945 @default.
- W2897225419 cites W1822869875 @default.
- W2897225419 cites W1862370067 @default.
- W2897225419 cites W1903523058 @default.
- W2897225419 cites W1925711586 @default.
- W2897225419 cites W1925927604 @default.
- W2897225419 cites W1967926172 @default.
- W2897225419 cites W1975131047 @default.
- W2897225419 cites W1988677906 @default.
- W2897225419 cites W1998495488 @default.
- W2897225419 cites W2004290558 @default.
- W2897225419 cites W2018486812 @default.
- W2897225419 cites W2020966893 @default.
- W2897225419 cites W2052859243 @default.
- W2897225419 cites W2057545666 @default.
- W2897225419 cites W2064376430 @default.
- W2897225419 cites W2068523052 @default.
- W2897225419 cites W2075465499 @default.
- W2897225419 cites W2088255080 @default.
- W2897225419 cites W2091575564 @default.
- W2897225419 cites W2097845786 @default.
- W2897225419 cites W2097957857 @default.
- W2897225419 cites W2099144023 @default.
- W2897225419 cites W2108927999 @default.
- W2897225419 cites W2264682687 @default.
- W2897225419 cites W2286136178 @default.
- W2897225419 cites W2301418989 @default.
- W2897225419 cites W2418158216 @default.
- W2897225419 cites W2466302516 @default.
- W2897225419 cites W2533194337 @default.
- W2897225419 cites W2560431464 @default.
- W2897225419 cites W2598216921 @default.
- W2897225419 cites W2603785418 @default.
- W2897225419 cites W2603972544 @default.
- W2897225419 cites W2763670669 @default.
- W2897225419 cites W2768235844 @default.
- W2897225419 cites W2770199280 @default.
- W2897225419 cites W2789314441 @default.
- W2897225419 cites W3021764655 @default.
- W2897225419 doi "https://doi.org/10.1158/1078-0432.ccr-18-1278" @default.
- W2897225419 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6333466" @default.
- W2897225419 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30327311" @default.
- W2897225419 hasPublicationYear "2019" @default.
- W2897225419 type Work @default.
- W2897225419 sameAs 2897225419 @default.
- W2897225419 citedByCount "46" @default.
- W2897225419 countsByYear W28972254192019 @default.
- W2897225419 countsByYear W28972254192020 @default.
- W2897225419 countsByYear W28972254192021 @default.
- W2897225419 countsByYear W28972254192022 @default.
- W2897225419 countsByYear W28972254192023 @default.
- W2897225419 crossrefType "journal-article" @default.
- W2897225419 hasAuthorship W2897225419A5002996984 @default.
- W2897225419 hasAuthorship W2897225419A5004894140 @default.
- W2897225419 hasAuthorship W2897225419A5005026596 @default.
- W2897225419 hasAuthorship W2897225419A5014882044 @default.
- W2897225419 hasAuthorship W2897225419A5017841270 @default.
- W2897225419 hasAuthorship W2897225419A5020173253 @default.
- W2897225419 hasAuthorship W2897225419A5024291093 @default.
- W2897225419 hasAuthorship W2897225419A5024482335 @default.
- W2897225419 hasAuthorship W2897225419A5025529463 @default.
- W2897225419 hasAuthorship W2897225419A5026717218 @default.
- W2897225419 hasAuthorship W2897225419A5031016267 @default.
- W2897225419 hasAuthorship W2897225419A5031234862 @default.
- W2897225419 hasAuthorship W2897225419A5034716746 @default.
- W2897225419 hasAuthorship W2897225419A5036587861 @default.
- W2897225419 hasAuthorship W2897225419A5049749003 @default.
- W2897225419 hasAuthorship W2897225419A5053008003 @default.
- W2897225419 hasAuthorship W2897225419A5056587248 @default.
- W2897225419 hasAuthorship W2897225419A5057043467 @default.